Blog

Tuesday 17th May - Hertility Health has announced its acquisition of Grip, a hormone testing company based in the Netherlands, allowing for their expansion in at-home fertility testing. This will expand the company's dataset, boosting their offerings in personalised...

30 March, 2022 A medical imaging spinout from University College London’s Institute of Neurology has secured office space in Sheffield’s Sheaf Bank Business Park with plans to expand in the region, it was announced today.  Gold Standard Phantoms develops products to...

London, 3rd March 2022 – A 2-year life sciences entrepreneurship project part funded  by Lambeth Council’s Economic Resilience Fund is projected to contribute more than  £8 million GVA to the borough and advance breakthrough healthcare technologies.  Capital...

LONDON, UK. 13/12/21:  Vinehealth raise $5.5mil seed round  Vinehealth, a digital health startup, offers personalised support for cancer patients via their app which has been downloaded 15,000 times since its launch. The technology, combining AI and behavioural...

LONDON, UK. 23/11/21:  Today, Motilent, the first company to specialise in the assessment of digestive diseases using AI medical image analysis, announces FDA 510K clearance in the USA. The rollout of this technology will be in partnership with Nuance AI solutions....

LONDON, UK. 2/11/21:  Baseimmune closes $4.8m  Baseimmune closes $4.8m funding round to future-proof vaccines Biotech startup Baseimmune, a spin-out from Imperial College, has raised $4.8m to develop the next generation of universal vaccines to protect against human...

LONDON, UK. 28/10/21:  GlamorousAI was today acquired by X-Chem - a leader in small molecule drug discovery. The startup, founded in 2020, uses their AI platform RosalindAI as a drug discovery tool. The acquisition hopes to create a leading service in machine...

PRESS RELEASE, 10 October 2021:  P4 Precision Medicine Accelerator announces the launch of P4SY, a programme supporting up to 50 companies in the South Yorkshire region focusing on bringing UK health and medtech companies to market, and promoting them to achieve key...

£1.3M seed financing raised from VC, state-aid backed entity and angel investors. The capital will be used to grow the team and productionise the existing prostate cancer work as well as build a general purpose multimodal AI platform. The platform will be additionally...